Thursday, December 12, 2019

 


Khiron Life Sciences Corp
(OTHER OTC: KHRNF) Add to Watchlist
$0.7180
+0.0160 (+2.28%)
as of Dec 12, 2019

Last 0.7180
Change +0.0160 (+2.28%)
Open 0.7040
Prev. Close 0.7020
Today's Range
0.6859 0.7325
52wk Range
0.5919 3.2800
Volume 115,900
Avg Volume 157,265
Sector All Sectors By Industry

Recent Headlines
-- First Hemp CBD brand to enter Latin American market under Dixie Brands joint venture  (full story)
KHRN.VN: 0.950 (+0.030), KHRNF: 0.7180 (+0.0160)
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announces that Mark Monaghan has resigned as a director of the Company and that Deborah Rosati FCPA, FCA, ICD.D has  (full story)
ACB.TO: 3.44 (+0.22), MEDFF: 18.8100 (-0.0700), KHRN.VN: 0.950 (+0.030), KHRNF: 0.7180 (+0.0160)
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States.  (full story)
KHRN.VN: 0.950 (+0.030), KHRNF: 0.7180 (+0.0160)
-- Khiron receives conditional TSXV approval for Latin American joint venture with Dixie Brands and U.S. distribution and sale of Kuida cosmeceutical line  (full story)
KHRN.VN: 0.950 (+0.030), KHRNF: 0.7180 (+0.0160), DIXI-U.CN: 0.210 (unch), DXBRF: 0.2120 (+0.0020)
Performance Comparison
Name Today 3-Month 1-Year
KHRNF +2.28% -16.51% -32.65%
DJIA +0.79% +7.87% +14.70%
S&P 500 +0.86% +9.73% +19.52%

Key Statistics
Annual EPS --
Dividend & Yield -- (--)
P/E Ratio N/A
Market Capitalization, $K --
Weighted Alpha -59.34
Standard Deviation +0.59
Profit Margin --
Beta N/A

Growth Rates
YTD -35.89%
1-Year -25.95%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.